Tower Research Capital LLC (Trc) Aeterna Zentaris Inc. Transaction History

Tower Research Capital LLC (Trc)

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	BUY	$0.33 - $0.42 $1,880 - $2,393	5,699 New	5,699 $2,000
Q2 2018 Aug 15, 2018	SELL	$1.19 - $2.62 $119 - $262	-100 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.46 - $2.41 $146 - $241	100 New	100 $0
Q4 2017 Feb 09, 2018	SELL	$1.87 - $2.7 $2,612 - $3,771	-1,397 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$1.81 - $2.23 $2,528 - $3,115	1,397	1,397 $4,000

Ticker AEZS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 4,855,880
Market Cap $19.4M
Description
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult grow...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.